137 related articles for article (PubMed ID: 38679975)
21. The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis.
He X; Bao W; Li X; Chen Z; Che Q; Wang H; Wan XP
Int J Mol Med; 2014 Feb; 33(2):325-32. PubMed ID: 24285342
[TBL] [Abstract][Full Text] [Related]
22. LncRNA HOTAIR enhances breast cancer radioresistance through facilitating HSPA1A expression via sequestering miR-449b-5p.
Zhang S; Wang B; Xiao H; Dong J; Li Y; Zhu C; Jin Y; Li H; Cui M; Fan S
Thorac Cancer; 2020 Jul; 11(7):1801-1816. PubMed ID: 32374522
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological and prognostic significance of homeobox transcript antisense RNA expression in various cancers: A meta-analysis.
Min SN; Wei T; Wang XT; Wu LL; Yu GY
Medicine (Baltimore); 2017 Jun; 96(23):e7084. PubMed ID: 28591050
[TBL] [Abstract][Full Text] [Related]
24. The association between LncRNA HOTAIR and cancer lymph node metastasis and distant metastasis: a meta-analysis.
Sun Z; Wu XY; Wu CL
Neoplasma; 2018; 65(2):178-184. PubMed ID: 29534577
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers.
Gökmen-Polar Y; Vladislav IT; Neelamraju Y; Janga SC; Badve S
Sci Rep; 2015 Mar; 5():8765. PubMed ID: 25739705
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
[TBL] [Abstract][Full Text] [Related]
27. Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis.
Liu FT; Pan H; Xia GF; Qiu C; Zhu ZM
Oncotarget; 2016 Dec; 7(50):83177-83186. PubMed ID: 27825121
[TBL] [Abstract][Full Text] [Related]
28. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of long non-coding RNA breast cancer anti-estrogen resistance 4 in human cancers: A meta-analysis.
Meng Y; Liu YL; Li K; Fu T
Medicine (Baltimore); 2019 May; 98(21):e15793. PubMed ID: 31124974
[TBL] [Abstract][Full Text] [Related]
30. Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.
Milevskiy MJ; Al-Ejeh F; Saunus JM; Northwood KS; Bailey PJ; Betts JA; McCart Reed AE; Nephew KP; Stone A; Gee JM; Dowhan DH; Dray E; Shewan AM; French JD; Edwards SL; Clark SJ; Lakhani SR; Brown MA
Hum Mol Genet; 2016 Aug; 25(15):3269-3283. PubMed ID: 27378691
[TBL] [Abstract][Full Text] [Related]
31. High expression of long noncoding RNA LUCAT1 correlates with a poor clinical outcome in solid tumors: A systematic review and meta-analysis.
Lv P; Ye T; Yang X; Liu H; Ye Z
Pathol Res Pract; 2020 Sep; 216(9):153047. PubMed ID: 32825932
[TBL] [Abstract][Full Text] [Related]
32. Circulating HOTAIR expression predicts the clinical response to neoadjuvant chemotherapy in patients with breast cancer.
Lu R; Zhang J; Zhang W; Huang Y; Wang N; Zhang Q; Qu S
Cancer Biomark; 2018; 22(2):249-256. PubMed ID: 29630518
[TBL] [Abstract][Full Text] [Related]
33. High lncRNA H19 expression as prognostic indicator: data mining in female cancers and polling analysis in non-female cancers.
Peng L; Yuan XQ; Liu ZY; Li WL; Zhang CY; Zhang YQ; Pan X; Chen J; Li YH; Li GC
Oncotarget; 2017 Jan; 8(1):1655-1667. PubMed ID: 27926484
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
Zhang G; Cai J
J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
[TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of HOTAIR for predicting clinical outcome in patients with digestive system tumors.
Ma G; Wang Q; Lv C; Qiang F; Hua Q; Chu H; Du M; Tong N; Jiang Y; Wang M; Zhang Z; Wang J; Gong W
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2139-45. PubMed ID: 25968902
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
[TBL] [Abstract][Full Text] [Related]
37. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of LncRNA-HOTAIR for patients with hepatocellular carcinoma: a meta-analysis.
Xu CL; Liu YH
Eur Rev Med Pharmacol Sci; 2022 Nov; 26(22):8444-8450. PubMed ID: 36459027
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of LncRNA HOTAIR in Colorectal Cancer: A Meta-analysis.
Chen S; Zhang C; Feng M
Open Med (Wars); 2020; 15():76-83. PubMed ID: 32104724
[TBL] [Abstract][Full Text] [Related]
40. Prognostic role of SPRY4-IT1 in female breast carcinoma and malignant tumors of the reproductive system: A meta-analysis.
Qin X; Yin Q; Gao J; Shi X; Tang J; Hao L; Li P; Zhu J; Wang Y
Medicine (Baltimore); 2022 Apr; 101(16):e28969. PubMed ID: 35482980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
